| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |